1. Home
  2. LNAI vs GDHG Comparison

LNAI vs GDHG Comparison

Compare LNAI & GDHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNAI
  • GDHG
  • Stock Information
  • Founded
  • LNAI N/A
  • GDHG 2008
  • Country
  • LNAI United States
  • GDHG China
  • Employees
  • LNAI N/A
  • GDHG N/A
  • Industry
  • LNAI Biotechnology: Pharmaceutical Preparations
  • GDHG Services-Misc. Amusement & Recreation
  • Sector
  • LNAI Health Care
  • GDHG Consumer Discretionary
  • Exchange
  • LNAI Nasdaq
  • GDHG Nasdaq
  • Market Cap
  • LNAI 23.9M
  • GDHG 19.4M
  • IPO Year
  • LNAI N/A
  • GDHG 2023
  • Fundamental
  • Price
  • LNAI $1.25
  • GDHG $4.55
  • Analyst Decision
  • LNAI
  • GDHG
  • Analyst Count
  • LNAI 0
  • GDHG 0
  • Target Price
  • LNAI N/A
  • GDHG N/A
  • AVG Volume (30 Days)
  • LNAI 9.2M
  • GDHG 34.8K
  • Earning Date
  • LNAI 11-14-2025
  • GDHG 07-11-2025
  • Dividend Yield
  • LNAI N/A
  • GDHG N/A
  • EPS Growth
  • LNAI N/A
  • GDHG N/A
  • EPS
  • LNAI N/A
  • GDHG N/A
  • Revenue
  • LNAI N/A
  • GDHG $16,666,899.00
  • Revenue This Year
  • LNAI N/A
  • GDHG N/A
  • Revenue Next Year
  • LNAI N/A
  • GDHG N/A
  • P/E Ratio
  • LNAI N/A
  • GDHG N/A
  • Revenue Growth
  • LNAI N/A
  • GDHG N/A
  • 52 Week Low
  • LNAI $0.81
  • GDHG $2.40
  • 52 Week High
  • LNAI $21.00
  • GDHG $1,968.41
  • Technical
  • Relative Strength Index (RSI)
  • LNAI N/A
  • GDHG 44.82
  • Support Level
  • LNAI N/A
  • GDHG $3.94
  • Resistance Level
  • LNAI N/A
  • GDHG $5.20
  • Average True Range (ATR)
  • LNAI 0.00
  • GDHG 0.41
  • MACD
  • LNAI 0.00
  • GDHG 0.14
  • Stochastic Oscillator
  • LNAI 0.00
  • GDHG 60.26

About LNAI Lunai Bioworks Inc. Common Stock

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

Share on Social Networks: